Erik Kakes | International Sales & Marketing Director, Applikon Biotechnology
Erik Kakes graduated in 1984 from van’t Hoff Institute in Rotterdam with specialization in Biochemistry. From 1984 until 1988 he worked for a sugar producing company, Cosun, optimizing Xanthan gum production. In 1988 he joined Applikon Biotechnology as a project manager. Via the R&D department he moved into Sales to become International Sales & Marketing Director. In 2008 he acquired the ownership of Applikon Biotechnology with Arthur Oudshoorn and Jaap Oostra through a management buyout. In 2020 the Swedish Getinge group acquired the shares of Applikon Biotechnology.
About Applikon Biotechnology
Applikon Biotechnology is a world leader in developing and supplying advanced bioreactor systems for the production of vaccines, antibodies, tissues, bio-pharmaceuticals, nutraceuticals and biosimilars in the Pharmaceutical industry, as well as enzymes, food, feed, bio-fuel, bio-chemicals and bio-plastics for Industrial Biotechnology. Applikon can guide a customer through the whole upstream process, from initial screening up to full-scale production, using the same platform.
Powered by: Hyphen Projects | Connect with us | Access Biotech China Newsletter | ||
Contact Us Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
| Subscribe
|
© Copyright 2021 by Hyphen Projects